Junshi Biosciences Announces Toripalimab plus Chemotherapy Significantly Improved Event-free Survival (EFS) versus Chemotherapy as Perioperative Treatment for Resectable Stage III Non-small Cell Lung Cancer (NSCLC) in Phase 3 Neotorch Study 21-04-2023, 03:01

Biodiversity Data from NORI-D Exploration Area Now Available on UNESCO’s Ocean Biodiversity Information System, Increases Biodiversity Records for the Clarion-Clipperton Zone by About 150% 3-07-2023, 18:45

Crusoe Closes $600M in Series D Round at $2.8 Billion Valuation to Power AI 12-12-2024, 20:00